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Abstract 
Thirteen contact lens patients with an objective and/or 
subjective diagnosis of d?Y eye were given a non-medicated 
(hydroxypropyl cellulose) slow..,.releasing artificial tear (SR-AT). 
After two weeks of daily use, a majority of the patients 
reported positive results, including two patients with giant 
papillary conjunctivitis (GPC) and one with nocturnal lagoph-
thalmos. It appears that this ocular insert may be beneficial 
for diagnosing the dry eye problems of contact lens wearers 
as well as non-contact lens wearers that are due to insuffi-
cient hydration and lubrication at the conjunctival/corneal 
and contact lens interface. 
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Slow Releasing Artificial Tears for 
Contact Lens Wearers with Dry Eyes 
It has been estimated that twenty to twenty-five percent 
of all persons seen in an eye clinic have subjective com-
plaints of dry eyes. 1 The basic cause of dry eye can usually 
be attributed to alterations of the preocular tear film, 
which consists of three basic components: 
1. The outer lipid layer is formed by secretions of 
the meibomian glands of the lids. Its function is to retard 
evaporation of the underlying aqueous layer and also to 
help stabilize thetear film against gravity. 
2. The middle aqueous layer is secreted by the major 
and accessory lacrimal glands. It is low in viscosity, and 
contains the water-soluble components of the tears; salts, 
glucose, urea, and traces of enzymes, proteins, and glycoproteins. 
J. The inner layer consists of mucin, which is spread 
over the epithelial cell membranes, and is anchored by the 
microvilli of the surface epithe~ial cells. This provides 
a hydrophilic surface for the aqueous tears to spread on, 
and lowers the surface tension for tear adherance. Mucin 
is produced by goblet cells of the conjunctiva, and covers 
the cornea via the spreading action of the eyelids. 2 'J 
Ba~ic causes df dry eye 
4 Tear production tends to decrease with age. Systemic 
diseases, physiological damage to the secretory glands, 
corneal/conjunctival tissue disruption, and mechanical 
problems can all manifest dry eye.5 
2 
Dry eye and contact lenses 
A contact lens, soft, gas-permeable, or hard, has 
an immediate thinning effect on the tear film. 6 This 
is because the contact lens tends to alter the normal 
spreading of the mucin, diminishes tear circulation with 
the corneal surface, and mechanical agitation of the secretory 
glands. 
While being worn, most soft contact lenses loose some 
of theit water content and become relatively dehydrated.? 
This increases the need for maintainance of proper integrity 
of the preocular tear film during the wearing hours. 
Corneal sensitivity is usually decreased by contact 
lens wear. This may cause the contact lens wearer to become 
a "lazy blinker'~" Blinking may become incomplete and decrease 
in frequency. This deviation from the normal 
four to eight blinks per minute may cause permanent dry 
spots and epithelial damage. 8 '9 
Until recently, the contact lens wearer with dry eyes 
has had to instill a liquid re-wetteing agent. This constant 
need for dropping has caused patient inconvenience to the 
point where some patients give up contact lens wear altogether. 
Case history 
Subjective symtoms of dry eye frequently arise during 
the case history. The patient is likely to complain of 
dry, burning eyes, with accompanying itching and foreign 
body sensation. Occasionally"' the patient will complain of 
J 
Case history, continued 
photophobia, and/or ropy discharge at the inner canthus. 
It is important to inquire of current and recurrent illnesses, 
medications, familial dry eye prediliction, vocational and 
avocational aspects. 
Discussionof SR-AT 
The slow releasing artificial tear (SR-AT, Lacrisert) 
is a rod shaped pellet of sterile, inert, water-soluble 
hydroxypropyl cellulose. It is approximately J.5 millimeters 
long, 1.27 millimeters in diameter, and we,ighs .5,milli:grams. 10 •11 
The SR-AT is inserted into the inferior cul-de-sac with a 
special "L"-shaped plastic applicator (inserts 1,2). Since 
Lacrisert contains no preservative, the integrity of the lipid 
layer is unaltered, as contrasted with many preserved re-
wetting formulations that contain cationic surfactants that 
disrupt the layer . 12 
The insert absorbs available tear fluid and swells 
many times larger than its original size (pictures 1~4)"' 
It gradually dissolves, releasing the hydroxypropyl cellulose, 
which physiologically resembles the mucin of the inner tear 
film layer. In some patients with marked tear deficiency, 
moisture may be insufficient to dissolve the insert. W.ith 
these patients, sterile saline drops a few times daily may 
help promote dissolution. 13 
Patients in selelcted studies who demonstrated chronic 
dry eye sym~oms not adequately relieved by the usage of 
the more conventional liquid tear substitutes have ,manifested 
4 
Discussion, continued 
marked relief and fewer objective corneal abnormalities when 
they used the SR-AT. 14 Some patients find it especially 
convenient because of the elimination of the need for 
constant dropping. 15 
Adverse effects of the SR-AT include transient blurring 
of vision, distorted vision, ocular discomfort nr irritating, 
matting and stickiness of the eyelashes, photophobia, edema 
of the eyelids, hyperemia, and hypersensitivity reactions. 16 ,l7 
Arthritic or neuromuscularly compromised individuals may 
have difficulty with installation. Soluble inserts need not 
be removed, thus limiting patient manipualtion to insertion 
only. 18 Some patients who inserted the Lacrisert at night 
have complained of very blurred vision the following day, 
making .tt diffillcult to drive or perform usual tasks. Decreases 
in visual acuity have also been reported. 19 
The literature concerning the effect of hydroxypropyl 
cellulose on the numerous types of plastic polymers that 
comprise contact lenses is limited. The approved liquid 
tear substitutes that commonly contain hydroxypropyl 
cellulose appearantly have not demonstrated any reactions 
with the contact lens materials. In fact, it would be 
highly unlikely that a reaction would occur since contact 
lens wetting and cushioning solutions are actually very 
:20 
similar in chemical composition to the lens polymers. 
5 
Methods 
Thirteen contact lens patients aged 20 to 27 (four gas-
permeable and nine soft lens wearers) were tested with the SR-AT 
monocularly for a total of two weeks. The left eye was regarded 
as the control eye, with no insert used in that eye. A patient 
instruction and information form was given to all patients 
(insert 3). 
An initial exam was performed to determine baseline data 
and diagnosis. The parameters included: 
1. Refractive status. Th~ maximum plus sphere to first 
readable 20/20 acuity for right and left eyes. 
2. Tear break-up time (B.U.T.). A moistened fluorescein 
strip was first applied to the bulbar conjunctiva. With a 
biomicroscope (25X), the interval between a complete blink 
and the appearance of the first dry spot observed in the tear 
film was determined. 
3. Rose bengal staining. A moistened rose bengal impreg-
nated strip was applied to the bulbar conjunctiva. This dye 
stains dev~alized cells and precipitated mucin, both of which 
tend to be present in chronically dry eyes. 
4. Biomicroscope examination. Conjunctival health, cor-
neal integrity (including edema), contact lens movement and 
cleanliness were recorded. 
5. Schirmer I and Schirmer IA Tests. Schirmer I (reflex 
secretion) was without local anesthesia, and IA (basal secre-
t . ) . th th . d f t . 1 . . 21 1on was w1 e a1 o op1ca propar1ca1ne. 
6. Visual acuity. Visual acuity with and without contact 
lens correction was recorded. 
6 
Each test was done initially, the next day (20 to 24 hours), 
after one week, and the close out exam after two weeks. The 
patient was then given a questionnaire for written evaluation 
of the SR-AT/contact lens system (insert 4). 
Results 
After the two week trial period, subjective and objective 
data was analyzed. One of the most significant results was 
observed in patients eight and nine (table 1). The two patients 
had histories of chronic giant papillary conjunctivitis (GPC). 
In the initial exam the papillae size and tarsal involvement 
t 'f' d 22 h 1 . f areas were quan 1-le . In t e c ose out exam, regress1on o 
the GPC was observed. No significant decrease in GPC involve-
ment was noted in patients one and ten. 
A t-test of the average breakup times before and with the 
SR-AT was determined. The increase in the breakup times with 
the insert was found to be insignificant at the five percent 
level. However, the SR-AT had an average breakup time of 
13.88 seconds as compared to 10.76 seconds for the control eye. 
Patient three, diagnosed as having nocturnal lagophthalmos 
reported increased contact lens comfort. Quantitatively, this 
patient demonstrated a decrease in breakup time with the SR-AT. 
However, her preakup time was considered normal before and 
while using the insert; so this finding is insignificant. 
Lens movement observed with the slit lamp in general was 
increased slightly with the insert. In patients two, eleven, 
and twelve the movement and centering properties improved 
dramatically. Magnified inspection of the lens revealed no 
remarkable residues attributable to the SR-AT. No adverse 
7 
effect on the contact lenses was observed. 
The range of time tolerance for the insert in the cul-de-
sac was six to twelve hours. After this length of time, the 
pellet expands and dissolves into annoying chunks that tend to 
float over the lens. Some patients removed the expanded 
insert when it reached the extreme stage of dissolution. 
No significant decrease in visual acuities with Lacrisert 
was revealed. However, subjective intermittent blurring was 
reported by all thirteen patients. The degree of blurring 
usually depended on the length of time the SR-AT had been in 
the eye; the longer in the eye, the more the blur. Patients 
four and six reported that they would not continue using the 
insert because it hindered vision too much. 
Nine patients reported increased comfort and felt that the 
SR-AT would be beneficial in this respect. Patient twelve, 
who was diagnosed as hypersensitive to thimerosal, found the 
non-preserved insert to increase his tolerable wearing time. 
Discussion 
We believe the regression of the GPC involvement in 
patients eight and nine can be attributed to the increased 
integrity of the tear film. Since more contact lens and tarsal 
conjunctiva lubrication was present, less physical abrasion 
resulted. Since it is believed that GPC is caused either by 
hypersensitivity to the contact lens materials or to the 
deposits on the lens, 23 it follows that less contact between 
the tissue and the plastic may reduce the GPC. 
All thirteen patients felt the cost of the SR-AT was 
prohibitive for daily use (about $20.00 for sixty inserts). 
8 
Usage on "bad" days is more of an economic reality. 
Ten patients felt that the SR-AT tended to swell to an 
uncomfortably large mass. Four patients suggested reducing them 
in size and in fact (to our chagrin) one patient cut the insert 
in half with a razor blade and had very good success. He noted 
that this would decrease usage cost in half. 
Handling problems in general did not occur. Those patients 
adept enough to insert and remove contact lenses probably will 
have no problems handling the SR-AT. Some occurrences of the 
SR-AT popping out after three or four hours were reported. 
Patient one who tended to wear her contact lenses up to eighteen 
hours per day found that insertion of the Lacrisert at noon 
provided good comfort late into the night. 
All thirteen patients had unremarkable case histories with 
regard to injuries, surgeries, diseases, corneal abnormalities, 
and systemic diseases. All experienced intermittant or constant 
contact lens irritation. The SR-AT helped to confirm a diag-
nosis of dry eye induced contact lens problems since the 
hydroxypropyl cellulose acts directly to supplement the inner 
mucin layer of the preocular tear film. 
Conclusion 
Clinically observed patients may experience dry eye due 
to conjunctival-corneal-contact lens interface tear 
component deficiencies. The SR-AT can be used by the eye 
care specialist-~·as a diagnostic aid for assessment of 
dry eye manifestations experienced not only byxcnon"':ie.anta.et.J: 
lens-rwe~rers, but contact lens wearers as well. 
Kelly J. Cochrane Mark A. Wedekind 
Dr. Alfred Furie 
__ , 
"'/;) ~-
Pacific University College of Optometry 
Forest Grove~ Oregon 
April 198J 
The support for this study was provided by the Oregon 
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SUBJECT AGE CONTACT LENS 
TYPE 
1 26 B&L toric soft 
'2 24 B&L U4 
3 23 J3olycon I 
4 25 CSI soft lens 
5 23 Polycon I 
6 26 Polycon I 
7 25 AOSOFT 
8 20 AOSOFT 
DIAGNOSIS 
GPC 
"eyes feel dry" 
dry eye 
nocturnal 
lagophthalmos, 
dry eye with 
decreased wearing 
time 
"eyes feel dry" 
dry eye with 
burning and red 
"eyes feel dry" 
tight lenses 
GPC "eyes feel 
dry" 
TABLE 1 
AVERAGE TEAR 
BREAKUP TIME 
WITHOUT WITH 
SR-AT SR-AT 
16 20 
,_, \J 
9 18 
15 10 
4 10 
15 15 
3 20 
20 20 
14 14 
OVERALL 
IMPRESSION 
neutral 
positive 
positive 
negative 
positive 
negative 
neutral 
negative 
COMMENTS 
increased lens movement 
decreased dry eye feeling 
increased contact lens 
comfort 
impaired movement of lens 
and irritated eye 
worked well but too 
expensive to use on a 
regular basis 
blurs vision too much 
eyes feel "goopy" next 
morning 
very blurred vi~ion 
decreased GPC 
TABLE 1 (continued) 
SUBJECT AGE CONTACT LENS DIAGNOSIS AVERAGE TEAR OVERALL COIVIMENTS 
TYPE BREAKUP TIIVIE IIVIPRESSION 
WITHOUT WITH 
SR-AT SR-AT 
9 20 Polycon I GPC & dry eye 6 10 positive decreased GPC, difficulty 
with handling 
10 24 B&L U4 GPC "eyes feel 15 14 positive minor foreign body 
dry" sensation, eyelash 
stickiness 
11 24 Durasoft toric dry eye, tight 7 8 positive tended to pop out after 
lenses six hours, if cut in half 
it works fi:m.e 
12 27 B&L U4 dry eye ~:~ ;_:·, -·'""' 8 10 positive eyes feel good next 
thimerosal morning 
sensitive 
'!":; 
13 25 Hydron toric dry eye tight 7 13 neutral on 1~bad" days it felt good, 
lenses prohibitive cost 
Photos of SR-AT over time 
4 hours 
Insert 4 
Tabulation of Questionnaire Responses 
Number of corresponding responses follows each question. 
Did you notice any of the following beneficial effects while 
using Lacri.sert: 
1. More comfortable contact lens wear? (7) 
2. Decreased redness of the eye? (3) 
3. Decreased itching and burning of the eye? (2) 
4. Decrease in dry eye problems? (9) 
5. Do you think that regular use of Lacriserts would increase 
your contact lens wearing time? (3) 
6. Are there any other beneficial effects that you noticed 
that ~re not mentioned above? (See Discussion) 
Did you notice any of the following adverse effects while using 
the Lacrisert? 
1. Momentary blurring of vision? If so, how often did it 
happen? (11) 
2. Did constant blurring of vision occur until the lens was 
removed and cleaned? If so, how often did it happen? (7) 
3. Eye irritation from the Lacrisert? (3) 
4. Foreign body sensation? (9) 
5. Matting or stickiness of eyelashes? (7) 
6. Difficulty with insertion? (3) 
7. Do you think that regular use of Lacriserts would decrease 
your contact lens wearing time? (3) 
8. Are there any other adverse effects that you noticed that 
are not listed above? (See Discussion) 
Do you have any suggestions on how Lacrisert may be improved 
upon as a product or in its method of use? (See Discussion) 
What is your overall impression of Lacrisert? 
7 subjects had a favorable impression of Lacrisert 
3 subjects had a negative impression of Lacrisert 
3 subjects had no strong feelings either favorable or nega-
tive of Lacrisert 
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INSTRUCTIONS 
FOR USING 
'LACRISERT' 
IHYDROXYPROPYL CELLULOSE 
OPHTHALMIC INSERT, MSDI 
NOTE: Your physician will demonstrate the 
proper use of LACRISERT. Please read 
and follow these instructions carefully 
for your subsequent use. 
Two applicators (one spare) are supplied with 
each package. 
Before opening the package of LACRISERT, 
wash your hands thoroughly with soap and 
water. 
STEP 1 On .a flat surface, open blister pocket 
slowly and smoothly by peeling back label area. 
Each blister pocket contains one LACRISERT 
ophthalmic insert. 
'LACRISERT' 
(Hydroxypropyl Cellulose 
Ophthalmic Insert, MSD) 
7189500 
STEP 2 Open applicator package with label 
side up. Avoid touching grooved tip of the ap-
plicator. Pick up applicator by the wide end and 
rinse the tip thoroughly under hot running tap 
water. Gently shake off excess water. 
STEP 3 Hold applicator with tip facing down 
and with forefinger on top to guide and apply 
pressure. Press the grooved tip of the ap-
plicator onto ttie center of the LACRISERT 
ophthalmic insert and it will adhere to the appli-
cator. 
STEP 4 Look into a mirror. Starting with the 
right eye, turn your head to the right so that the 
colored part of the eye is close to your nose. 
Use your free hand to grasp the lower lid be-
tween the thumb and index finger. Pull the lid 
away from the eyeball and create a pocket be-
tween the white part of the eyeball and the lid. 
--,-·~·-·,'·~-
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'LACRISERT' 
(Hydroxypropyl Cellulose 
Ophthalmic Insert, MS D) 
STEP 5 Place the tip of the applicator contain-
ing LACRISERT into the pocket. Avoid touch-
ing the colored part of the eye. 
Lift applicator, look down, then release lower 
eyelid. LACRISERT should remain deep in the 
pocket recess of the eye. 
Repeat procedure with left eye, turning head 
to the left so that the colored part of the eye is 
close to your nose. 
Rinse the applicator thoroughly under hot 
running tap water after use. Gently shake off 
visible water droplets and promptly return it to 
the storage container. Note that the storage 
container provides space for a strip of two 
LACRISEHT ophthalmic inserts next to the ap-
plicator storage compartment. 
IMPORANT 
Should the removal of the LACRISERT oph-
thalmic insert be necessary, follow these in-
structions. 
1. Locate LACRISERT by pulling the lid 
away from the eyeball while looking for 
LACRISERT in a mirror. 
2. Then close the eyelids. 
3. When located, move LACRISERT upward 
with your fingers through the closed eyelids. 
4. Keep the lids against the eyeball and 
LACRISERT should slip over the lid margin 
so that you can remove it with a clean facial 
tissue without touching the colored part of 
the eye. 
CAUTION: Because this product may produce 
transient blurring of vision, you should exercise 
caution when operating hazardous machinery 
or driving a motor vehicle. 
Store below 30°C (86°F). 
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Insert 2 
STERILE OPHTHALMIC INSERT 
LACRISERT® 
(HYDROXYPROPYL CELLULOSE 
OPHTHALMIC INSERT, MSD) 
DESCRIPTION 
LACRISERT* IHydroxypropyl Cellulose 
Ophthalmic Insert, MSDI is a rod-shaped, wa-
ter soluble, ophthalmic preparation made of hy-
droxypropyl cellulose, 5 mg_ LACRISERT 
contains no preservatives or other ingredients. 
It is about 1.27 mm in diameter by about 3.5 
mmlong. 
LACRISERT is supplied in packages of 60 
un!ts~ together v-.::th i!h..:stiatod instn.:ctions gnd 
a special applicator for removing LACRISERT 
from the unit dose blister and inserting it into 
the eye. A spare applicator is included in each 
package. 
ACTIONS 
LACRISERTacts to stabilize and thicken the 
precorneal tear film and prolong the tear film 
breakup time which is usually accelerated in 
patients with dry eye states. LACRISERT also 
acts to lubricate and protect the eye. 
LACRISERT usually reduces the signs and 
symptoms resulting from moderate to severe 
dry eye syndromes. 
INDICATIONS 
LACRISERT is indicated in patients with 
moderate to severe dry eye syndromes, includ-
ing keratoconjunctivitis sicca. LACRISERT is 
indicated especially in patients who remain 
symptomatic after an adequate trial of therapy 
with artificial tear solutions. 
LACRISERT is also indicated for patients 
with: 
Exposure keratitis 
Decreased corneal sensitivity 
Recurrent corneal erosions 
LACRISERT U!Wally reduces the signs and 
symptoms resuh:ng from moderate to severe 
dry eye syndromes, such as conjunctival hy-
peremia, corneal and conjunctival staining with 
rose bengal, exudation, itching, burning, for-
eign body sensation, smarting, photophobia, 
dryness and blurred or cloudy vision. Progres-
sive visual deterioration which occurs in some 
patients may be retarded, halted, or sometimes 
reversed. 
In a multicenter crossover study the 5 mg 
LACRISERT administered once a day was 
compared to artificial tears used four or more 
times daily. There was a significant prolonga-
tion of tear film breakup time and a significant 
decrease in foreign body sensation associated 
with dry eye syndrome in patients during treat-
ment with inserts as compared to artificial 
tears. Improvement, as measured by ameliora-
tion of symptoms, by slit lamp examination and 
by rose bengal staining of the cornea and con-
junctiva, was greater in most patients with 
"Registered trademark of MERCK & CO., INC. 
COPYRIGHT© MERCK & CO., INC., 1979 
All rights reserved 
LACRISERT® 
(Hydroxypropyl Cellulose 
Ophthalmic Insert, MSD) 
moderate to severe symptoms during treat-
ment with LACRISERT. Patient comfort was 
usually better with LACRISERTthan with artifi-
cial tears solution, and most patients preferred 
LACRISERT. 
In most patients treated with LACRISERT 
for over one year, improvement was observed 
as evidenced by amelioration of symptoms 
generally associated with keratoconjunctivitis 
sicca suth as burning, tearing, foreign body 
sensation, itching, photophobia and blurred or 
cloudy vision. 
During studies in healthy volunteers, a thick-
ened precorneal tear film was usually observed 
through the slit lamp while LACRISERT was 
present in the conjunctival sac. 
CONTRAINOICATIONS 
LACRISERT is contraindicated in patients 
who are hypersensitive to hydroxypropyl cellu-
lose. 
WARNINGS 
Instructions for inserting and removing 
LAC A ISERT should be carefully followed. 
PRECAUTIONS 
Because this product may produce transient 
blurring of vision, patients should be instructed 
to exercise caution when operating hazardous 
machinery or driving a motor vehicle. 
ADVERSE REACTIONS 
The following adverse reactions have been 
reported in patients treated with LACRISERT, 
but were in most instances mild and transient: 
Transient blurring of vision (See PRECAU-
TIONS) 
Ocular discomfort or irritation 
Matting or stickiness of eyelashes 
Photophobia 
Hypersensitivity 
Edema of the eyelids 
Hyperemia 
-::..-., 
DOSAGE AND ADMINISTRATION 
Or.a LACRISERT ophthalmic insert in each 
eye once daily is usually sufficient to relieve the 
symptoms associated with moderate to severe 
dry eye syndromes. Individual patients may re-
quire more flexibility in the use of LACRISERT; 
some patients may require twice daily use for 
optimal results. 
LACRISERT is inserted into the inferior cul-
de-sac of the eye beneath the base of the tar-
sus. Illustrated instructions are included in each 
package, but initially patients must be in-
structed in the correct method of insertion. 
While in the ophthalmologist's office, the pa-
tient should read the instructions, then practice 
insertion and removal of LACRISERT until pro-
ficiency is achieved. 
NOTE: Occasionally LACRISERT is inadver-
tently expelled from the eye, especially in pa-
tients with shallow conjunctival fornices or 
when the eye is rubbed. If required, another 
LACRISERT ophthalmic insert may be in-
serted. If experience indicates that transient 
blurred vision develops in an individual patient, 
the patient may want to remove LACR IS EAT a 
LACRISER'T"' 
(Hydroxypropyl Cellulose 
Ophthalmic Insert, MSD) 
few hours after insertion to avoid this. 
LACRISERTophthalmic insert may be 
if needed. 
HOW SUPPLIED 
No. 3380-LACRISERT, a rod-shaped, 
ter-soluble, ophthalmic preparation 
hydroxypropyl cellulose, 5 mg, is 
follows: 
N DC 0006-3380-60 in packages 
60 unit doses, two reusable applicators and a 
storage container. 
Store below 30°C (86°F). 
MERCK SHARP & DOHME, Division of Merck & Co., INC. 
West Point, Pa. 19486 
Issued February 1981 
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1, Pacific University College 
A. Title of Project: 
B. Principal Investigator: 
C. Advisor~ 
D. Location: 
E. Date: 
2. Description of Project: 
Release Forrn 
of Optometry 
The Use of Lacrisert in Conjunction 
with Soft Contact Lenses. 
Kelly Cochrane and Mark Wedekind 
Al Furie OD 
Pacific University College of 
Optometry, Forest Grove, Oregon 
1932 
This project will determine the compatibility of Lacrisert with 
soft contact lens wearers. The Lacrisert will be placed into 
the right eye only while contact lenses are worn in both eyes. 
After two weeks of Lacrisert usage, you will fill out a question-
naire on the effectiveness of the Lacr.isert and on any problems 
encountered during its use. 
J. Descri tion of Risks: 
1 Lacrisert may produce momentary blurring of VlSlon. 
2) You may experience initial eye discomfort or irritation 
from the Lacrisert. 
J) There is a slight chance that you may develop fu~ allergic 
reaction to the Lacrisert. 
4) From time to time you may experience irritation from bright 
lights. 
5) The Lacrisert may become contaminated if inserted ""'i th 
uncleansed hands. This could lead to fu~ eye infection. 
4. Description of Benefits: 
This experiment will provide valuable informat~on on the use 
of Lacrisert with soft contact lens patieYlts who have dry eye 
symptoms. If Lacrisert proves to be compatible with soft 
contact lens wearers it could provide them with the following 
benefits: 1) longer wearing time, 2) more comfortable contact 
lens wear, J) decreased redness of the eye, 4) decreased 
itching and burning of the eye, and 5) decreased dryness of 
the eye. 
5. Comuensation and Medical Care: 
If you are injured in this experiment it is possible that you 
will not receive compensation or medical care from Pacific 
University, the experimenters, or any organization associated 
with the e:x-periment; however, all reasonable care will be 
used to prevent injury. 
6. Alternatives Advantageous to Subjects: 
Not Applicable. 
·Insert J, continued 
7. Offer to .P..nswer any Inquiries: 
The exper·imen-ter will be happy to answer a.'1.y queSL;lons that 
you may have at any time during the course of the project. 
8. Freedom to Withdraw: 
You are free to withdraw your consent and.to discontinue 
participation in this project or activity at any time without 
prejudice to you. 
I have read and understand the above. I am 18 years of age or 
over. 
Printed Name 
Signed ______________________________________ Date 
Address 
Phone 
Name and address of a person not living with you who will always 
know your address 
Insert 3, continued 
Instruction Handout for the Subject 
1) Since Lacrisert may produce momentary blurring of vision 
you should exercise cau-c1on when operating hazardous 
machinery or driving a motor vehicle. 
2) There is a slight chance that you may be allergic to the 
Lacrisert. If you experience blood-shot eyes, swelling of 
eyelids with a burning or itching sensation you are to 
discontinue use of the Lacrisert illmediately and notify 
Experimenters as soon as possible • 
'1 
-cn.e 
. phone: 357-6151 ext, 208 for the optometry clinic 
357-8580 for Mark Wedekind 
357-7412 for Kelly Cochrane 
J) Remember to thoroughly wash your hands before inserting 
the Lacrisert (see instructions next page). 
4) Only insert the Lacrisert into the right eye. 
5) You must return after the first day of Lacrisert usage 
and after the first and second week of usage for a progress 
exam. 
